SCHEMBL4848033

SCHEMBL4848033

CNCCCCOc1ccc(-c2ccccc2C)cc1C(=O)/C=C/c1ccccc1CN(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 1/20 0.40
SLC6A9 P48067 2/20 0.40
HRH1 P35367 2/20 0.39
BACE1 P56817 6/20 0.37
CYP1A2 P05177 3/20 0.36
CYP3A4 P08684 3/20 0.36
TP53 P04637 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 1/20 0.36
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
AR P10275 1/20 0.34
CYP2D6 P10635 2/20 0.34
ALDH1A1 P00352 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
PTPN1 P18031 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4856175 1.00 PTPN11 (0.40) PTPN11SLC6A9HRH1BACE1CYP1A2
SCHEMBL4848040 0.91 HRH1 (0.39) PTPN11SLC6A9HRH1BACE1CYP1A2
SCHEMBL4854469 0.91 SLC6A9 (0.43) PTPN11SLC6A9HRH1ALDH1A1
SCHEMBL4856457 0.91 SLC6A9 (0.43) PTPN11SLC6A9HRH1ALDH1A1
SCHEMBL4847435 0.89 SLC6A9 (0.46) PTPN11SLC6A9HRH1ARALDH1A1
SCHEMBL4853568 0.89 SLC6A9 (0.46) PTPN11SLC6A9HRH1ARALDH1A1
SCHEMBL4852558 0.87 MAOB (0.42) PTPN11SLC6A9
SCHEMBL4845305 0.87 MAOB (0.42) PTPN11SLC6A9
SCHEMBL4853354 0.87 SLC6A9 (0.40) PTPN11SLC6A9LMNAKEAP1NFE2L2
SCHEMBL4852918 0.87 SLC6A9 (0.40) PTPN11SLC6A9LMNAKEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed